C2 L-erythro Ceramide (d18:1/2:0)

C2 L-erythro Ceramide (d18:1/2:0) Suppliers list
Company Name: Yichang Zhongyitai Trading Co., Ltd.  
Tel: 0717-6449896 13886658719
Email: root@zhongyitai.com
Company Name: Alfa Chemistry  
Tel: 1-516-6625404
Email: support@alfa-chemistry.com
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: Shanghai Hongye Biotechnology Co. Ltd  
Tel: 400-9205774 400-920-5774
Email: sales@glpbio.cn
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
C2 L-erythro Ceramide (d18:1/2:0) Basic information
Product Name:C2 L-erythro Ceramide (d18:1/2:0)
Synonyms:C2 L-erythro Ceramide (d18:1/2:0);Acetamide, N-[(1R,2S,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-;Acetyl-L-erythro-sphingosine;N-[(1R,2S,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-acetamide
CAS:150338-90-2
MF:C20H39NO3
MW:341.53
EINECS:
Product Categories:
Mol File:150338-90-2.mol
C2 L-erythro Ceramide (d18:1/2:0) Structure
C2 L-erythro Ceramide (d18:1/2:0) Chemical Properties
Boiling point 532.4±50.0 °C(Predicted)
density 0.964±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility Chloroform: soluble; DMF: soluble; DMSO: soluble; Ethanol: soluble; Methanol: soluble
form A solid
pka13.50±0.20(Predicted)
Safety Information
MSDS Information
C2 L-erythro Ceramide (d18:1/2:0) Usage And Synthesis
DescriptionC2 L-erythro Ceramide is a bioactive sphingolipid and a cell-permeable analog of naturally occurring ceramides. It stimulates cholesterol efflux in CHO cells expressing the human ABCA1 receptor when used at a concentration of 10 μM, however, this efflux is >50% less than that stimulated by C2 ceramide . C2 L-erythro Ceramide also induces cell cycle arrest in the G0\G1 phase and a 50-fold increase in sphingosine accumulation as well as inhibits growth of HL-60 leukemia cells. [Matreya, LLC. Catalog No. 1847]
UsesC2 L-Erythro ceramide (d18:1/2:0) is a cell-permeable sphingolipid. C2 L-Erythro ceramide (d18:1/2:0) induces cell cycle arrest in the G0/G1 phase and inhibits cell growth[1][2].
References[1] Baek MY, et al. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells. Arch Pharm Res. 2001 Apr;24(2):144-9. DOI:10.1007/BF02976482
[2] Bielawska A, et al. Selectivity of ceramide-mediated biology. Lack of activity of erythro-dihydroceramide. J Biol Chem. 1993;268(35):26226-26232. PMID:8253743
C2 L-erythro Ceramide (d18:1/2:0) Preparation Products And Raw materials
Tag:C2 L-erythro Ceramide (d18:1/2:0)(150338-90-2) Related Product Information
C18 L-erythro Ceramide (d18:1/18:0) C2 dihydroceramide C2 ceramide C6 L-erythro Ceramide (d18:1/6:0) C2 L-threo Ceramide (d18:1/2:0)